Recruitment unclearEUCTR 2014-003803-31

Adjunct pioglitazone IN THE TREATMENT OF Bipolarity.

This historical record does not confirm current site availability.

Historical research recordSpain

The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Who could participate?

This study is for people with bipolarity. Other eligibility criteria apply.

Listed locations: Spain
Study phase: Phase 3

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Recruitment unclear
Enrollment listed in the registry: Not clearly listed
Sponsor: Hospital Universitario Araba (Sede Santiago)
Sponsor type: Hospital / academic medical center
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: Spain
Age range: Not clearly listed
Official registry ID: EUCTR 2014-003803-31
Official title: Show the full official title
Adjunct pioglitazone IN THE TREATMENT OF BIPOLAR DISORDER.

Get this study by email

Recruitment & locations

Status unknown

Spain

Registry details

Historical country statuses

Spain — Ongoing

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Hospital Universitario Araba (Sede Santiago), a hospital or academic medical center.

Who can participate?

This study is for people with bipolarity. Other eligibility criteria apply.

Want to explore more studies?

Explore studies